01 1Maprimed
01 1LEFLUNOMIDE
01 1Argentina
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-12-16
Pay. Date : 2018-09-04
DMF Number : 32988
Submission : 2018-09-07
Status : Active
Type : II
20
Maprimed Sa, based in Argentina, is a pharmaceutical company.
One of their notable products is LEFLUNOMIDE, with a corresponding US DMF Number 32988.
Remarkably, this DMF maintains an Active status since its submission on September 07, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 16, 2018, and payment made on September 04, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
